Medtech Strategic/Start-Up Partnerships: Structuring For Success
According to a panel of strategic investors speaking at a recent IN3 meeting, structured deals that can help manage risk for medtech start-ups seeking funding and strategics looking for growth opportunities are on the rise.
You may also be interested in...
European biotech executives, entrepreneurs and investors are much more optimistic today about the sector’s growth prospects than just a few years ago – that’s despite lingering negatives like the region’s small number of mid-sized companies, a lack of investors willing to finance beyond seed and Series A rounds, and the relative dearth of executive talent.
The company’s leadership team is “determined to transform Medtronic from being a primarily device provider today into the premier global medical technology solutions partner of tomorrow,” CEO Omar Ishrak said.
Edwards Lifesciences announced that it was acquiring private Dutch company BMEYE BV, the developer of a new noninvasive technology for hemodynamic monitoring. Noninvasive hemodynamic monitoring has long been “The Holy Grail” in critical care, and non-invasive technology opens up new applications and new markets for Edwards as well.